HHS Seeks Another Delay Of 340B Drug Price Ceilings

By Rachel Graf (September 1, 2017, 2:46 PM EDT) -- The U.S. Department of Health and Human Services has again proposed delaying the implementation of a final rule that would establish drug price ceilings and fine drugmakers that knowingly charge more than the established price ceiling for products purchased through the 340B Drug Pricing Program....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!